Anja Gesierich Selected Research

Anja Gesierich Research Topics

Disease

30	Melanoma (Melanoma, Malignant) 05/2024 - 01/2016
14	Neoplasms (Cancer) 05/2024 - 10/2013
8	Uveal melanoma 05/2024 - 10/2013
8	Skin Neoplasms (Skin Cancer) 11/2022 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
3	Merkel Cell Carcinoma 11/2022 - 11/2017
2	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 11/2022
2	Glioma (Gliomas) 12/2022 - 11/2022
2	Exanthema (Rash) 01/2021 - 02/2019
2	Sarcoidosis (Schaumann Disease) 10/2020 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2018
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2019 - 01/2017
2	Disease Progression 01/2018 - 01/2017
1	Leukocytosis (Pleocytosis) 11/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Infections 01/2021
1	Neutropenia 01/2021
1	Vitiligo 02/2020
1	Acute Kidney Injury (Acute Renal Failure) 12/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 12/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2019
1	Bullous Pemphigoid (Pemphigoid) 08/2019
1	Erythema Multiforme 02/2019
1	Melanosis (Freckles) 10/2018
1	Ulcerative Colitis 01/2018
1	Pancreatitis 01/2018
1	Crohn Disease (Crohn's Disease) 01/2018
1	Thyroiditis 01/2018
1	Colitis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Hidradenitis Suppurativa 04/2016
1	Blister (Bulla) 01/2006
1	Acute Generalized Exanthematous Pustulosis 01/2006
1	Herpes Zoster 09/2004
1	Dermatitis 09/2004

Drug/Important Bio-Agent (IBA)

20	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2017
9	NivolumabIBA 11/2022 - 01/2016
9	IpilimumabIBA 11/2022 - 01/2017
7	pembrolizumabIBA 01/2022 - 01/2016
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 02/2019
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2019
3	AntibodiesIBA 11/2022 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2020
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 01/2020
2	avelumabIBA 11/2022 - 07/2021
2	VemurafenibIBA 01/2021 - 04/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2020 - 05/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
2	HhAntag691IBA 01/2019 - 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 05/2024
1	Peptide Hydrolases (Proteases)FDA Link 05/2024
1	SteroidsIBA 03/2024
1	Infliximab (Remicade)FDA Link 03/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2024
1	dabrafenibIBA 09/2022
1	trametinibIBA 09/2022
1	AntigensIBA 05/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Dipyrone (Metamizole)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	cobimetinibIBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 05/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	NucleotidesIBA 01/2019
1	Diltiazem (Cardizem)FDA LinkGeneric 01/2006

Therapy/Procedure

20	Therapeutics 05/2024 - 10/2013
8	Immunotherapy 12/2022 - 01/2018
4	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2017
2	Drug Tapering 09/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
2	Aftercare (After-Treatment) 06/2021 - 01/2021
1	Combined Modality Therapy 09/2023
1	Radiotherapy 01/2020